Literature DB >> 31995009

Primary Sjögren's Syndrome and Cardiovascular Disease.

Konstantinos Melissaropoulos1, Dimitrios Bogdanos2, Theodoros Dimitroulas3, Lazaros I Sakkas2, George D Kitas4, Dimitrios Daoussis5.   

Abstract

Sjögren's syndrome is a rheumatic autoimmune disease that primarily affects middle-aged women and runs a slowly progressing course with sicca symptoms being the prevalent manifestation. Premature atherosclerosis and increased cardiovascular (CV) morbidity and mortality are frequently encountered in rheumatic diseases characterized by significant systemic inflammation, such as the inflammatory arthritides, systemic vasculitides and systemic lupus erythematosus. In the same context, chronic inflammation and immune aberrations underlying Sjögren's syndrome are also reported to be associated with augmented risk of atherosclerosis. Increased CV disease (CVD) frequency has been found in recent meta-analyses. The involvement of the CV system is not a common feature of Sjögren's syndrome; however, specific manifestations, such as autoantibody-mediated heart block, pericarditis, pulmonary arterial hypertension and dysautonomia, have been described. This review focuses on studies addressing CV morbidity in Sjögren's syndrome and presents current data regarding distinct CV features of the disease. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Sjögren's syndrome; anti-Ro antibodies; atherosclerosis; cardiovascular morbidity; dysautonomia; echocardiography; heart block

Mesh:

Substances:

Year:  2020        PMID: 31995009     DOI: 10.2174/1570161118666200129125320

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  6 in total

Review 1.  Cardiac involvement in primary Sjӧgren's syndrome.

Authors:  Li Qin; Yiwen Zhang; Xiaoqian Yang; Qiang Luo; Han Wang
Journal:  Rheumatol Int       Date:  2021-08-13       Impact factor: 2.631

2.  Exposure-lag-response associations between extreme environmental conditions and primary Sjögren's syndrome.

Authors:  Ling Xin; Yongjian Zhu; Jian Liu; Yanyan Fang; Jingui Xie
Journal:  Clin Rheumatol       Date:  2021-09-14       Impact factor: 2.980

3.  Predictive Value of Echocardiographic Strain for Myocardial Fibrosis and Adverse Outcomes in Autoimmune Diseases.

Authors:  Fuwei Jia; Xiao Li; Dingding Zhang; Shu Jiang; Jie Yin; Xiaojin Feng; Yanlin Zhu; Yingxian Liu; Yuanyuan Zhu; Jinzhi Lai; Huaxia Yang; Ligang Fang; Wei Chen; Yining Wang
Journal:  Front Cardiovasc Med       Date:  2022-02-21

4.  Adipose-derived stem cells postpone the progression of Sjögren's syndrome by upregulating the Hippo signaling pathway.

Authors:  Zizhan Li; Xinli Fan; Xiuying Xu; Qin Zhou; Guimiao Xing; Gangli Liu
Journal:  Exp Ther Med       Date:  2022-07-22       Impact factor: 2.751

5.  The role of Th9 CD4+ T cells and IL-9 during primary Sjogren's syndrome.

Authors:  Jie Yang; Juan Su; Kexia Chai; Huihui Liu
Journal:  J Clin Lab Anal       Date:  2022-08-09       Impact factor: 3.124

6.  Adropin Serum Levels in Patients with Primary Sjögren's Syndrome.

Authors:  Marijana Janković Danolić; Dijana Perković; Marin Petrić; Igor Barišić; Katarina Gugo; Joško Božić
Journal:  Biomolecules       Date:  2021-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.